Tempus Al TEM 深 沪
已收盘 07-02 16:00:00 美东时间
60.27
-1.330
-2.16%
华盛通- 最 高63.0999
- 今 开61.10
- 成交量 596.63万股
- 最 低 58.91
- 昨 收 61.60
- 总市值 108.22亿
- 52周最高 104.32
- 市盈率 静 --
- 换手率 3.32%
- 52周最低 41.73
- 委 比 -33.33%
- 总股本 1.80亿
- 历史最高 104.32
- 量 比 0.73
- 振 幅 6.80%
- 历史最低 22.89
- 每 手 1
- 风险率 14.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
07-02 18:41
Freedom Capital Markets Initiates Coverage On Tempus AI with Hold Rating, Announces Price Target of $59
Freedom Capital Markets analyst Gene Mannheimer initiates coverage on Tempus AI (NASDAQ:TEM) with a Hold rating and announces Price Target of $59.
07-01 16:46
Ambry Study Shows RNA Testing May Clarify Uncertain Genetic Results
Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ:TEM), announced peer-reviewed research demonstrating the potential for variant-specific RNA testing to
06-09 18:07
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
Owkin and Sanofi expand their AI partnership with a five-year deal to develop agentic systems aimed at accelerating drug research.
06-05 19:01
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Tempus AI shares are trading higher. The company announced expansion of new indications to its AI-enabled Next platform ahead of the 2026 ASCO Annual Meeting.
Tempus AI shares are trading higher. The company announced expansion of new ind...
05-29 01:55
Why Is Tempus AI Stock Surging On Thursday?
Discover why Tempus AI Inc (NASDAQ:TEM) stock is surging today following major platform expansions and landmark clinical data ahead of ASCO 2026.
05-29 01:47
美股异动 | 软件股集体上扬！Snowflake涨近36%，Palantir涨超4%；微软涨超3%，将于下周发布新的编码模型
软件股集体上扬！Snowflake涨近36%，Palantir涨超4%；量子计算概念普涨，IBM涨超4%；微软涨超3%，将于下周发布新的编码模型>>
05-28 22:09
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
Bristol Myers Squibb expands AI efforts through Anthropic and Tempus partnerships as shares edge higher Wednesday.
05-21 01:09
Tempus AI Partners With Bristol Myers Squibb Over Leveraging AI, Multimodal Real-World Data, Data Science Techniques For Clinical Trial Designs
Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new initiative with Bristol Myers Squibb (NYSE: BMY). This collaboration aims to leverage AI,
05-14 20:40
